One issue that remains to be fully addressed is the choice of primer(s) that would appropriately stimulate both DC-mediated T-helper 1 (Th1) polarization of tumor-specific CD4+ T cell and cytotoxic CD8+ T cell (CTL) responses. The gene discussed is CD8A; the disease is neoplasm.